Prenatal Sonographic Prediction of Placental Histology and Function
ConditionPregnancy Complications
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-60
SponsorEndeavor Health
About this trial
The purpose of this two-phase observational study is to investigate the use of ultrasonography to predict placental pathology at the time of delivery.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients with delivery in NorthShore University HealthSystem,
Ultrasound available within 4 weeks of delivery with adequate placental images
Placental pathology available
Disqualifiers
Multiple gestation
Exposed: Patients with singleton gestation with fetal growth restriction at 20-28 weeks with a plan to deliver at NorthShore Highland Park Hospital Evanston Hospital. Patients must have a first-trimester ultrasound (<14 weeks) to confirm pregnancy dating available in the electronic medical record.
Unexposed: Patients who present for routine ultrasound evaluation at 36-38 weeks with normal fetal growth with a plan to deliver at NorthShore Highland Park Hospital or NorthShore Evanston Hospital.
Exposed: Multiple gestation, major fetal anomaly
Trial population
Pregnant patients who plan to deliver at NorthShore University HealthSystem
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Imaging characteristics
Imaging characteristics will be compared by those with and without placental pathology found at the time of delivery
Time frame
Image characteristics will be collected every 2 weeks prenatally, and placenta will be collected at the time of delivery for analysis, this will be up to 22 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov